Sandro Santagata
Boston, MA, USA
Harvard Medical School
About
Associate Pathologist in Neuropathology, Brigham and Women’s Hospital, Department of Pathology; Associate Professor in Pathology, Harvard Medical School
Harvard Medical School
We identify and target vulnerabilities in tumors to improve patient outcome and survival, focusing on primary brain tumors and tumors that metastasize to the brain.
Through genomics, chemical biology, and multiplexed imaging we explore the fundamental mechanisms that allow tumor cells to develop their most malignant features along with our colleagues in the Lab for Systems Pharmacology and the Ludwig Center at Harvard.
As experimental pathologists in the Department of Pathology at Brigham and Women’s Hospital (Brigham Health), we routinely move from model systems to primary human tumor tissues and back.
Harvard Medical School
research
Interests
Craniopharyngioma
Childhood craniopharyngiomas are rare tumors usually found near the pituitary gland (a pea-sized organ at the bottom of the brain that controls other glands) and the hypothalamus (a small cone-shaped organ connected to the pituitary gland by nerves).Craniopharyngiomas are usually part solid mass and
Low-Grade Glioma
Low-Grade Gliomas also called astrocytomas are the most common cancer of the central nervous system in children. They represent a heterogeneous group of tumors that can be discovered anywhere within the brain or spinal cord. Although surgical resection may be curative, up to 20% of children still su
Meningioma
A meningioma is a primary central nervous system (CNS) tumor. This means it begins in the brain or spinal cord. Overall, meningiomas are the most common type of primary brain tumor. However, higher grade meningiomas are very rare.